ABS’s technology is based on direct electrochemical communication between the sensor and the analyte. It offers extremely sensitive, selective, accurate detection of biomarkers without need tracers and labeling. The nanobiomimetic sensors offer 100-fold higher power and energy density for energy storage devices without a need electrolyte.
Primary Application Area: Healthcare & Medical Devices
Technology Development Status: Prototype
Technology Readiness Level: TRL 5
Vetted Programs/Awards: ABS was the finalist in energy storage devices for National American Security Challenge competition (ASC) in 2010. ABS has been the National Innovation Showcase awardee in 10 years (Techconnect World conference); ABS was in the DOD’s Mentor-Protégé in 2010-14. ABS won the Techconnect National Innovation Award 2017 and 2018.
Organization Type: Mid-stage Startup (A or B)
GOVT/EXTERNAL FUNDING SOURCES
External Funding to Date: ABS has privately funded of $1,274,600 from 2006-2021, did not include government grants. Currently an investor team of Heiser Partners Mr. Tom Heiser /Frank Majer is joined our team.